Indication

Malignant brain neoplasm

A malignant brain neoplasm is a cancerous, rapidly growing mass of abnormal cells arising within or metastatic to the central nervous system tissues of the brain. Read more about Malignant brain neoplasm

14 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Malignant brain neoplasm therapies.

Showing 1–9 of 14 drugs

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
AMNEAL BIOSCIEN

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ZYDUS PHARMACEU

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
STI PHARMA, LLC

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
DR.REDDY'S LAB

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ALEMBIC PHARMAC

CARMUSTINE

NITROSOUREAS·MALIGNANT BRAIN NEOPLASM·+6
ATHENEX PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Malignant brain neoplasm preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant brain neoplasm.

A malignant brain neoplasm is a cancerous, rapidly growing mass of abnormal cells arising within or metastatic to the central nervous system tissues of the brain.

It can affect pediatric and adult populations, developing primarily from glial cells, neuronal tissue, or meninges—such as in high-grade gliomas and medulloblastomas—or secondarily via hematogenous dissemination from distant primary malignancies like lung or breast cancers.

Pathophysiologically, these tumors exhibit cellular atypia, high mitotic activity, microvascular proliferation, and local tissue infiltration, often disrupting the blood-brain barrier.

Clinically, their expansion within the rigid cranial vault produces vasogenic edema, elevated intracranial pressure, persistent headaches, seizures, and focal neurological deficits.

Personalize your experience

Follow Malignant brain neoplasm and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it